January 4, 2017 / 12:46 PM / 7 months ago

BRIEF-Cidara Therapeutics completes enrollment in phase 2 Radiant trial

1 Min Read

Jan 4 (Reuters) - Cidara Therapeutics Inc

* Cidara Therapeutics completes enrollment in phase 2 Radiant trial evaluating novel antifungal CD101 topical in vulvovaginal candidiasis

* Cidara expects to report topline data for radiant in Q1 of 2017 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below